Eight Roads-backed DeltaHealth, an innovative healthcare services provider specializing in cardiovascular diseases, has raked in over $100 million in a new round of financing, per a company statement on Friday.
Swire Pacific Limited, a Hong Kong-based conglomerate that owns majority equity interests in Swire Properties and Pacific Airways, has led the round. Eight Roads also made follow-on investments.
The capital injection makes Swire Pacific the second largest investor in DeltaHealth, which is looking to work on its cardiovascular strategy, among others.
Last year, DeltaHealth Hospital performed 294 aortic surgeries, ranking second in Shanghai. Subsequently, in 2021, the hospital has successfully conducted the first transcatheter heart valve replacement (TAVR).
In 2016, Fidelity’s investment arm Eight Roads pumped in capital in DeltaHealth. The company now owns two flagship sub-brands – Shanghai DeltaHealth Hospital, and outpatient medical clinic DeltaWest Clinic.
Going forward, Shanghai DeltaHealth Hospital plans to ramp up efforts to expand its surgical specialities in a bid to provide quality healthcare services to local and expats in the city.
“As Swire expands its healthcare portfolio, I believe it can lead to potential synergies with DeltaHealth. Its solid background in property development will also be of great value to us as we build out phase two in the future,” said DeltaHealth CEO David Hoidal.
“Our strategy is to invest in…healthcare service providers which serve the rapidly growing middle class in major city clusters where we already have a presence,” added Swire Pacific Limited chairman Guy Bradley.